| A Study of the Immune Response to Heplisav in Healthy Older Adults (NCT01999699) | Dynavax Technologies Corporation | 2013-11-01 |
| Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination (NCT01983540) | Sanofi Pasteur, a Sanofi Company | 2013-10-01 |
| Optimizing HBV Management During Anti-CD20 Antibodies (NCT03155984) | The University of Hong Kong | 2013-10-01 |
| Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya (NCT01878435) | Johns Hopkins Bloomberg School of Public Health | 2013-10-01 |
| RCT Study on Granulocyte Colony-stimulating Factor(G-CSF) Treatment of Hepatic Failure (NCT02331745) | Beijing 302 Hospital | 2013-10-01 |
| Non-invasive Biomarkers of Fibrosis in Pediatric Liver Diseases (NCT01988753) | Baylor College of Medicine | 2013-10-01 |
| A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject (NCT01917357) | Crucell Holland BV | 2013-09-01 |
| Prospective Stuy in Evaluating Hepatic Fibrosis Related to Hepatitis B Virus Using Non-invasive Parameters (NCT01962155) | Peking University First Hospital | 2013-08-01 |
| A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384) (NCT01727271) | Merck Sharp & Dohme LLC | 2013-08-01 |
| Immune Response in Patients With Hepatitis B and C Infection (NCT02275221) | Mid and South Essex NHS Foundation Trust | 2013-08-01 |
| Evaluation of the Long-term Persistence of Immunity to Hepatitis B, in Adolescents Vaccinated in Infancy With Engerix™-B Kinder (NCT01847430) | GlaxoSmithKline | 2013-07-19 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Hepatitis B Vaccination in Infants (NCT01896596) | Public Health England | 2013-07-01 |
| Blood Collection Biorepository for Liver Disease Research (NCT03025074) | State University of New York at Buffalo | 2013-07-01 |
| Widespread vs. Selective Screening for Hepatitis B Infection Prior to Chemotherapy (NCT01970254) | M.D. Anderson Cancer Center | 2013-06-24 |
| Lay Health Worker Model to Reduce Liver Cancer Disparities in Asian Americans (NCT02760537) | Thomas Jefferson University | 2013-04-01 |
| New Methods to Measure the Immune Response to Hepatitis B Vaccine (NCT01821547) | University of Oxford | 2013-03-01 |
| HBRN: Immune Regulation and Costimulation in Natural History and Therapeutic Outcome of Chronic Hepatitis B (NCT01796457) | University of Pennsylvania | 2013-03-01 |
| Development of Read-outs in Healthy, Hepatitis B Virus Naive Adults Vaccinated With the Hepatitis B Surface Antigen (HBsAg) in Combination With a GlaxoSmithKline (GSK) Biologicals' Adjuvant System (NCT01777295) | GlaxoSmithKline | 2013-02-25 |
| Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests (NCT01790633) | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 2013-02-01 |
| Prophylactic Use of Entecavir for HBsAg Positive Lymphoma Patients Treated With Rituximab-based Immunochemotherapy (NCT01768195) | Peking University | 2013-01-01 |
| Prophylactic Use of Entecavir for HBsAg Negative/HBcAb Positive/Hepatitis B Virus DNA Negative Patients With Lymphoma (NCT01765231) | Peking University | 2013-01-01 |
| A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant (NCT01856413) | Biotest | 2012-12-01 |
| Combination Therapy of Pegylated Interferon Alfa-2a and Tenofovir Versus Tenofovir Monotherapy in Chronic Hepatitis B (NCT01369212) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2012-11-01 |
| Tubular Function in Asian-American Patients Receiving TDF or ETV for HBV Treatment (NCT01715987) | New Discovery LLC | 2012-10-01 |
| Thousand Asian American Study (NCT02596438) | University of California, Davis | 2012-10-01 |
| Phase III, Study to Evaluate the Efficacy of Two Different HBV Vaccination Schemes in Patients With Hepatic Cirrhosis (NCT01884415) | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2012-09-07 |
| Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection (NCT01368497) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2012-09-01 |
| Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection (NCT01606163) | Green Cross Corporation | 2012-08-01 |
| Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes Mellitus (NCT01627340) | GlaxoSmithKline | 2012-07-24 |
| Efficacy of Peg-interferon α-2a in Hepatitis B Patients Treated by Entecavir Without HBeAg Loss (NCT01599130) | Sun Yat-sen University | 2012-07-01 |
| Observational Study on Prevalence of Host and Viral Genotypes in Chronic Hepatitis B and Hepatitis C Patients in India (NCT01772121) | Gilead Sciences | 2012-05-01 |
| Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBV (NCT01125696) | Centers for Disease Control and Prevention | 2012-05-01 |
| Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B (NCT01369199) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2012-05-01 |
| Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy (NCT01590615) | Gilead Sciences | 2012-04-26 |
| Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine (NCT01353703) | GlaxoSmithKline | 2012-04-16 |
| A Study Evaluating GS-9620 in Treatment Naive Subjects With Chronic Hepatitis B (NCT01590641) | Gilead Sciences | 2012-04-01 |
| A Study Evaluating GS-9620 in Virologically Suppressed Subjects With Chronic Hepatitis B Virus Infection (NCT01590654) | Gilead Sciences | 2012-04-01 |
| Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis (NCT01720238) | Beijing Friendship Hospital | 2012-03-01 |
| Efficacy and Safety of Hepatitis B Vaccine in Chronic Kidney Disease Patients (NCT01933412) | Tel-Aviv Sourasky Medical Center | 2012-03-01 |
| Application of HBV Rapid Tests as a Tool for Wide-Use Screening (NCT01767597) | Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba | 2012-02-01 |
| HBV DNA Levels During Pregnancy in Chronic Hepatitis B (NCT01610115) | Chang Gung Memorial Hospital | 2012-01-01 |
| Assessment and Monitoring of Renal Proximal Tubular Tolerance of Nucleoside and Nucleotide Analogues Using Early Screening Tools in Patients Chronically Mono-infected With Hepatitis B Virus (NCT01500265) | University Hospital, Limoges | 2011-12-01 |
| Immunogenicity, Safety and Tolerability of a Fully Liquid Pentavalent (DTwP-Hib-Hep B) Vaccine in Infants 6-8 Weeks of Age (NCT01470287) | Novartis Vaccines | 2011-12-01 |
| Modified Process Hepatitis B Vaccine in Japanese Young Adults (V232-062) (NCT01463683) | Merck Sharp & Dohme LLC | 2011-11-29 |
| Prevention of Hepatitis B Virus Mother-to-child Transmission by Serovaccination. (NCT01810835) | Hopital Lariboisière | 2011-11-01 |
| Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) (NCT01453998) | GlaxoSmithKline | 2011-10-14 |
| Study to Evaluate the Safety and Immunogenicity of Combined Hepatitis A/B Vaccine With MenACWY-CRM Conjugate Vaccine (NCT01453348) | Novartis Vaccines | 2011-10-01 |
| Cellular Immunity in Adult Hepatitis B-vaccinated Serologic Non-responders (NCT01451801) | University of Aarhus | 2011-10-01 |
| Cohort of Hepatitis B Research of Amsterdam (NCT01462981) | Public Health Service of Amsterdam | 2011-09-01 |
| Study of the Booster Effect of DTaP-IPV-Hep B-PRP~T Combined Vaccine or Infanrix Hexa™ and Prevenar™ in Healthy Infants (NCT01444781) | Sanofi Pasteur, a Sanofi Company | 2011-09-01 |
| Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine (NCT01548326) | Nematollah Jonaidi Jafari | 2011-09-01 |
| Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection (NCT01350648) | National Institutes of Health Clinical Center (CC) | 2011-08-23 |
| Expression of Th9 Cells and Poor/Non-responsiveness to Hepatitis B Vaccination (NCT01441609) | Beijing Municipal Science & Technology Commission | 2011-08-01 |
| Hepatitis B Seroepidemiology Among Young Adults (NCT01973582) | National Taiwan University Hospital | 2011-07-01 |
| Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ (NCT01358825) | GlaxoSmithKline | 2011-05-30 |
| Behavioral Science Aspects of Rapid Test Acceptance (NCT01317784) | California State University, Long Beach | 2011-05-01 |
| Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vaccination (NCT01357720) | Crucell Holland BV | 2011-05-01 |
| Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in Newborns (NCT01349283) | Crucell Holland BV | 2011-05-01 |
| Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children (NCT01333813) | GlaxoSmithKline | 2011-04-26 |
| Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB) (NCT01300234) | GlaxoSmithKline | 2011-03-30 |
| HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B (NCT01298037) | University of Pennsylvania | 2011-02-01 |
| "Real-life" Cohort of Patients With Chronic Hepatitis B Virus Infection (NCT01732081) | University Hospital, Strasbourg, France | 2011-01-01 |
| Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission (NCT03977987) | Huashan Hospital | 2011-01-01 |
| Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) (NCT01248884) | GlaxoSmithKline | 2010-12-09 |
| Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy (NCT01341743) | Nanfang Hospital, Southern Medical University | 2010-12-01 |
| Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination (NCT02323308) | ANRS, Emerging Infectious Diseases | 2010-12-01 |
| Hepatitis B Research Network Pediatric Cohort Study (HBRN) (NCT01263600) | University of Pittsburgh | 2010-12-01 |
| Hepatitis B Challenge Dose in Adults (V232-059-10) (NCT01251276) | Merck Sharp & Dohme LLC | 2010-11-30 |
| A Confirmatory Study of Hepabulin IV in HBsAg Positive Liver Transplantation Recipients (NCT01513850) | SK Chemicals Co., Ltd. | 2010-10-01 |
| Duration of Long-term Immunity After Hepatitis B Virus Immunization (NCT01182311) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2010-09-08 |
| Bioequivalence of LB80380 Free Base and Maleate Salt Tablets (NCT01427868) | LG Life Sciences | 2010-09-01 |
| Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose (NCT01171989) | GlaxoSmithKline | 2010-08-18 |
| A Study of DTaP-IPV-Hep B-PRP-T Vaccine Given With Prevenar™ and Rotarix™ in Healthy Latin American Infants (NCT01177722) | Sanofi Pasteur, a Sanofi Company | 2010-08-01 |
| Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in Taiwan (NCT01334567) | Gilead Sciences | 2010-08-01 |
| Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants (NCT02366286) | Mayo Clinic | 2010-07-27 |
| Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients (NCT01131065) | Instituto Grifols, S.A. | 2010-07-01 |
| Evaluation of Antibody Persistence and Immune Memory Against the Hepatitis B Antigen in Previously Vaccinated Children (NCT01138098) | GlaxoSmithKline | 2010-06-07 |
| Brief Intervention for Drug Misuse in the Emergency Department (NCT01124591) | Rhode Island Hospital | 2010-06-01 |
| Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants (NCT01090453) | GlaxoSmithKline | 2010-05-17 |
| Study to Evaluate the Immunogenicity and Reactogenicity of a Booster Dose of GSK2036874A Vaccine in Healthy Toddlers (NCT01106092) | GlaxoSmithKline | 2010-05-13 |
| Adolescents' Response to Hepatitis B Vaccine Booster Dose (NCT01341275) | Baylor College of Medicine | 2010-04-01 |
| Combination Hepatitis A and B Vaccine to Induce Immunity in Non-responders (NCT01126853) | Mount Sinai Hospital, Canada | 2010-04-01 |
| Study of Quinvaxem for Vaccination Against Diphtheria, Pertussis, Tetanus, Hepatitis B and Diseases Caused by Haemophilus Influenzae Type B (NCT01362517) | Crucell Holland BV | 2010-04-01 |
| Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control Vaccine (NCT01105559) | Sanofi | 2010-04-01 |
| Notification of Donors With Positive Microbiology Markers (NCT01050881) | NHS Blood and Transplant | 2010-03-01 |
| UCLA-Amity Parolee Health Promotion Study (NCT01844414) | University of California, Los Angeles | 2010-02-01 |
| Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult (NCT01037114) | GlaxoSmithKline | 2010-01-27 |
| Simvastatin for the Treatment of Chronic Hepatitis B (NCT00994773) | Bader, Ted, M.D. | 2009-12-01 |
| Antibody Persistence & Immune Memory in Healthy Adults Previously Vaccinated With Twinrix Adult (NCT01000324) | GlaxoSmithKline | 2009-11-06 |
| Acceptability of Hepatitis B Vaccination in General Practitioners and Paediatricians (NCT01777074) | GlaxoSmithKline | 2009-11-01 |
| Persistence of Immunity Against Hepatitis B in 12-13 Year Old Adolescents After Infant Hepatitis B Vaccination (NCT00984139) | GlaxoSmithKline | 2009-10-12 |
| Evaluating Blood Glucose Levels During Infusion With HepaGam B (HBIG) in Post-liver Transplant Patients (NCT00998426) | Georgetown University | 2009-10-01 |
| Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students (NCT01861613) | Hui Zhuang | 2009-09-01 |
| Immunogenicity and Safety Study of GSK Biologicals' GSK2202083A Vaccine in Healthy Infants at 2, 3 and 4 Months of Age (NCT00970307) | GlaxoSmithKline | 2009-08-13 |
| Prophylaxis of Hepatitis B Virus Recurrence After Liver Transplantation (NCT01139203) | Shanghai Jiao Tong University School of Medicine | 2009-08-01 |
| Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIV (NCT00926146) | University of California, Los Angeles | 2009-07-01 |
| Epidemiological Study in Children and Adolescents With Chronic Hepatitis B (NCT01163240) | Novartis Pharmaceuticals | 2009-06-01 |
| Acceptability of Hepatitis B Vaccination in General Population (NCT01782794) | GlaxoSmithKline | 2009-05-01 |
| Evaluation of Antibody Persistence & Immune Memory in Subjects Vaccinated During Adolescence With Twinrix™ (NCT00875485) | GlaxoSmithKline | 2009-05-01 |